Iram Fatima, Ikbale El-Ayachi, Hilaire C Playa, Jackelyn A Alva-Ornelas, Aysha B Khalid, William L Kuenzinger, Peter Wend, Jackelyn C Pence, Lauren Brakefield, Raisa I Krutilina, Daniel L Johnson, Ruth M O'Regan, Victoria Seewaldt, Tiffany N Seagroves, Susan A Krum, Gustavo A Miranda-Carboni
Triple-negative breast cancers (TNBCs), which lack specific targeted therapy options, evolve into highly chemo-resistant tumors that metastasize to multiple organs simultaneously. We have previously shown that TNBCs maintain an activated WNT10B-driven network that drives metastasis. Pharmacologic inhibition by ICG-001 decreases β-catenin-mediated proliferation of multiple TNBC cell lines and TNBC patient-derived xenograft (PDX)-derived cell lines. In vitro, ICG-001 was effective in combination with the conventional cytotoxic chemotherapeutics, cisplatin and doxorubicin, to decrease the proliferation of MDA-MB-231 cells...
December 17, 2019: Cancers